Comedian the late Lee Ji-soo has been dead for three years. The late Lee Ji-soo was found dead in her rented room in ...

In the hot and humid summer months, people tend to be more alert to food poisoning, gastroenteritis, skin diseases, and ...

Spread the love“`html Urinary Tract Infections (UTIs) are among the most common bacterial infections, affecting millions of individuals worldwide each year. While they can be uncomfortable and painful ...

Adults with complicated urinary tract infections, including kidney infections, now have an oral antibiotic option that ...

The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs). Utebzi is indicated for ...

The U.S. Food and Drug Administration has approved Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs). Utebzi is indicated for cUTIs, ...

GSK and Spero Therapeutics have scored an FDA approval for Utebzi as the first oral carbapenem antibiotic for complicated urinary tract infections (cUTI). With the nod, patients in the United States ...

First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to ...

Please provide your email address to receive an email when new articles are posted on . Utebzi is the first oral carbapenem antibiotic approved for adults with complicated UTIs in the United States.

What Is It, and Why Does It Matter? Utebzi (tebipenem pivoxil) is an oral carbapenem antibiotic. It blocks proteins that bacteria use to build their cell walls, which stops them from growing, allowing ...

Please provide your email address to receive an email when new articles are posted on . Zaynich had a higher treatment response rate vs. meropenem in trials and was generally well tolerated. The ...

SHORT HILLS, N.J., June 1, 2026 /PRNewswire/ -- Wockhardt today announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepime and zidebactam), a novel intravenous ...